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We introduce hmmSeq, a model-based hierarchical Bayesian tech-
nique for detecting differentially expressed genes from RNA-seq data.
Our novel hmmSeq methodology uses hidden Markov models to ac-
count for potential co-expression of neighboring genes. In addition,
hmmSeq employs an integrated approach to studies with techni-
cal or biological replicates, automatically adjusting for any extra-
Poisson variability. Moreover, for cases when paired data are avail-
able, hmmSeq includes a paired structure between treatments that
incoporates subject-specific effects. To perform parameter estimation
for the hmmSeq model, we develop an efficient Markov chain Monte
Carlo algorithm. Further, we develop a procedure for detection of dif-
ferentially expressed genes that automatically controls false discovery
rate. A simulation study shows that the hmmSeq methodology per-
forms better than competitors in terms of receiver operating charac-
teristic curves. Finally, the analyses of three publicly available RNA-
seq data sets demonstrate the power and flexibility of the hmmSeq
methodology. An R package implementing the hmmSeq framework
will be submitted to CRAN upon publication of the manuscript.
1. Introduction. RNA-seq has revolutionized the study of gene expres-
sion. RNA-seq success may be attributed to its low noise, high-throughput
and ability to interrogate allele-specific expression and isoforms [Zhao et al.
(2014), Auer, Srivastava and Doerge (2012)]. Most RNA-seq studies aim to
identify differentially expressed (DE) genes between samples corresponding
to different treatments or biological conditions, for example, cancer tissue
versus normal tissue, genetically engineered animals versus control animals,
or patients exposed to two or more kinds of treatments. These differentially
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expressed genes usually form the starting point of more extensive studies
such as integration of expression data with transcription factor binding [Kar-
lebach and Shamir (2008)], RNA interference [Pe’er and Hacohen (2011)]
and DNA methylation [Louhimo and Hautaniemi (2011)], all of which can
lead to a better understanding of regulatory mechanisms. Currently avail-
able methods for RNA-seq data analysis assume that differential expression
of genes occurs independent of the genomic loci of each gene [Auer and Do-
erge (2011), Robinson and Smyth (2007, 2008), Hardcastle and Kelly (2010),
Robinson, McCarthy and Smyth (2010), Si and Liu (2013)]. However, the lit-
erature contains evidence that neighboring genes on the chromosome tend to
be co-expressed [Caron et al. (2001), Singer et al. (2005), Michalak (2008)].
To account for and take advantage of this potential co-expression, here we
introduce hmmSeq.
Our hmmSeq framework incorporates potential co-expression by model-
ing differential expression across the genome using hidden Markov models
(HMM). In the hmmSeq framework that we propose, neighboring gene co-
expression may occur in two ways: in differential expression across treat-
ments and in mean expression magnitude. Thus, we model gene differential
expression across treatments using an HMM with three states: not differ-
entially expressed, under- or over-expressed. This HMM takes advantage
of the potential co-differential expression by borrowing information across
neighboring genes on the chromosome. In addition, we model gene mean
expression magnitude with an HMM with two states: low expression and
high expression. The latter HMM borrows information across the genome
to increase estimation precision of the mean expression magnitude of each
gene. As we show in the simulation study in Section 4, the use of informa-
tion both from neighboring genes and across the genome increases detection
power and reduces false discovery.
The existing methods for RNA-seq data analysis do not account for the
potential co-expression of neighboring genes. Robinson and Smyth (2007,
2008) use the negative binomial distribution to model over-dispersed data
through dispersion parameters. Specifically, Robinson and Smyth (2008) as-
sume a common dispersion parameter across all tags (or genes), whereas
Robinson and Smyth (2007) assume tag-wise (or gene-wise) dispersion pa-
rameters. To estimate these dispersion parameters, they assume a Gaussian
hierarchical hyperprior that is estimated using empirical Bayes. After that,
the gene-wise dispersion parameters are estimated by maximum weighted
likelihood. This method is implemented in edgeR [Robinson, McCarthy and
Smyth (2010)]. The baySeq method of Hardcastle and Kelly (2010) is an
empirical Bayes approach that is also based on the negative binomial dis-
tribution. An empirically determined prior distribution is derived from the
entire data set, and rather than producing significance values, this method
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calculates posterior probabilities of multiple models of differential expres-
sion, ranking the genes by the model probabilities. Blekhman et al. (2010)
analyze RNA-seq data by a Poisson generalized linear mixed-effect model,
which explains inter-individual variability through the inclusion of a ran-
dom individual-specific effect. Data are fitted under the null and alternative
models gene by gene, then a likelihood ratio test is conducted to compute
p-values, and the false discovery rate (FDR; defined as the proportion of
incorrect calls among the genes declared as DE) is controlled by the method
of Storey and Tibshirani (2003). Auer and Doerge (2011) have proposed the
two-stage Poisson model (TSPM) which assumes data contain both overdis-
persed and nonoverdispersed genes. This technique seeks to reduce FDR by
first separating the overdispersed genes from the nonoverdispersed genes,
and then fitting separate models to compute the p-values. Benjamini and
Hochberg (1995) FDR controlling is applied on each set of p-values to iden-
tify DE genes. Si and Liu (2013) developed a test for the hypothesis that the
log fold change belongs to a subset of the real line. By assuming parameters
under a null and alternative hypothesis come from different distributions,
they estimate this mixture distribution from the data, then the test statis-
tic is obtained as the ratio of unconditional probability from null parame-
ter space over unconditional probability from full space. All these previous
methods assume that the genes are conditionally independent. However, the
exploratory data analysis we present in Section 2.2 suggests dependence
among neighboring genes. Our hmmSeq method addresses this dependence.
Our hmmSeq framework may also accommodate the case when there is no
dependence among the expression of neighboring genes. Specifically, HMMs
include as particular cases mixture models. In particular, the number of
components of the mixture model will be the same as the number of states
in the HMM. Thus, when there is no co-differential expression, the result will
be a mixture model with three components that correspond to a gene being
not differentially expressed, under- or over-expressed. Likewise, when there
is no dependence in mean expression magnitude among neighboring genes,
the resulting mixture model will have two components, one component for
low expression genes and another for high expression genes. Note that the
proportion of genes in each component and the parameters of the generating
model for each component will be estimated from the data. Thus, even with-
out neighboring genes dependence, the hmmSeq framework will still borrow
information across the genome to learn about each of the mixture compo-
nents and, as a result, increase estimation precision and detection power.
We model extra-Poisson variability in an indirect manner. If the exper-
iment contains technical replicates (i.e., samples from the same subject),
then the literature provides evidence that the RNA-seq counts are Poisson
distributed [Marioni et al. (2008), Bullard et al. (2010)]. On the other hand,
if the experiment contains biological replicates, then the RNA-seq counts
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will have extra-Poisson variability [Langmead et al. (2010), Robinson and
Smyth (2007)]. This extra-Poisson variability may be a result of across-
subjects variability or slight differences in the experimental conditions when
the samples were taken or analyzed. While the RNA-seq literature usually
uses the negative binomial distribution to model the extra-Poisson variabil-
ity, another way to deal with this extra-variability is through the use of
the Poisson distribution together with random effects. We prefer the latter
because it provides a framework that can flexibly deal with known sources
of extra-Poisson variability such as, for example, biological variation among
subjects. In the case of paired data considered in Section 5.3, we deal with
the biological variation by including for each gene subject-specific random
effects. Moreover, for nonpaired data we implicitly deal with the subject-
specific random effects (and any other source of extra-Poisson variability)
by assuming that for nondifferentially expressed genes the differential treat-
ment effect parameter may come from a normal distribution centered at
zero. Hence, for nondifferentially expressed genes the differential treatment
effect parameter is a sum of the random effects of subjects and other hidden
sources. In addition to facilitating the implementation of our HMM frame-
work, this aspect of our model increases robustness with respect to hidden
unforeseen sources of variability.
We have investigated in three fronts the practical usefulness and adequacy
of HMMs and mixture components models for RNA-seq data analysis. First,
we have performed an exploratory data analysis presented in Section 2.2 that
studies for two real RNA-seq data sets the empirical statistical properties
of preliminary estimates of differential expression parameters and mean ex-
pression magnitude parameters. Two patterns emerge from this exploratory
data analysis: the existence of three differential expression states and of two
mean expression magnitude states; and a possible dependence across neigh-
boring genes. Second, we have performed a simulation study that considers
all four possible combinations of HMMs and mixture components models
for differential expression and mean expression magnitude. This simulation
study compares the performance of our hmmSeq framework with compet-
ing RNA-seq analysis methodologies. In all four possible cases, our hmm-
Seq framework beats the competing methods in terms of receiver operating
characteristic curves. Finally, we have used the deviance information crite-
rion (DIC) [Spiegelhalter et al. (2002)] to decide among the four possible
combinations of HMMs and mixture components models what is the most
adequate model for each of three real RNA-seq data sets. Our use of the
DIC is justified by its good performance in a simulation study presented in
Section 4. The DIC indicates dependence across neighboring genes for two of
the three data sets. Therefore, in this paper we provide further evidence that
for some biological processes neighboring genes on the chromosome tend to
be co-expressed.
HMMSEQ: A HIDDEN MARKOV MODEL 5
We take a full Bayesian analysis approach and develop a Markov chain
Monte Carlo algorithm to exploit the posterior distribution of the model
parameters. To simulate the differential effects and the mean effect mag-
nitudes, we develop an efficient Metropolis–Hastings algorithm for hidden
Markov models. In addition, we use the output of the MCMC algorithm to
identify differentially expressed genes while controlling for false discovery
rate. Specifically, we use a Bayesian approach for controlling the FDR level
proposed by Newton et al. (2004) and further studied by Mu¨ller, Parmigiani
and Rice (2007). We demonstrate the advantages and benefits of our hmm-
Seq methodology by analyzing three RNA-seq data sets. The first data set
[Marioni et al. (2008)] consists of five technical replicates each of a kidney
and liver RNA sample. The second data set [Zeng et al. (2012)] consists of six
biological replicates extracted from two regions, frontal pole and hippocam-
pus, of normal human brains. Finally, the third data set [Henn et al. (2013)]
consists of paired B-cell samples data of day 0 (before vaccination) and day 7
(post-vaccination) for 3 pre-vaccinated subjects. Therefore, we demonstrate
the power and flexibility of the hmmSeq methodology on three types of
RNA-seq data: technical replicates, biological replicates and paired samples.
The remainder of the paper is organized as follows. Section 2 describes the
details of the hmmSeq model and informally demonstrates the necessity for
hidden Markov models in Section 2.2. Section 3 describes the posterior in-
ference procedure based on Markov chain Monte Carlo (MCMC) techniques
and the procedure for identification of DE genes. Section 4 uses simulated
data to demonstrate the effectiveness of hmmSeq relative to well-known
techniques for RNA-seq. The Marioni et al. (2008), Zeng et al. (2012) and
Henn et al. (2013) data sets are analyzed in Sections 5.1, 5.2 and 5.3. In
all cases, the results are compared and contrasted with those of existing
approaches to demonstrate the success of hmmSeq. A functional analysis of
the detected sets of DE genes provides further evidence of the reliability of
the procedure. An R package implementing the hmmSeq framework will be
submitted to CRAN upon publication of the manuscript.
2. A Bayesian hierarchical model for RNA-seq data. We focus on two-
treatment comparisons. For a given chromosome c, let Yijkc denote the
integer-valued gene read of the kth replicate of gene i under treatment j, for
gene i= 1,2, . . . , Ic, treatment j = 1,2, and replicate k = 1,2, . . . ,Kj on chro-
mosome c. The genes are sequentially arranged so that consecutive indices
correspond to neighboring genes on the chromosome. We assume that
Yijkc
indep
∼ Poisson(λijkc) where
log(λi1kc) = βic −∆ic + ρ1k and(2.1)
log(λi2kc) = βic +∆ic + ρ2k,
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where βic denotes the mean expression magnitude of gene i and 2∆ic de-
notes the log-fold change between the treatments. The treatment-specific
replicate effects are represented by ρjk. We observe that the treatments are
a priori interchangeable in equation (2.1). The differential treatment effect
∆ic for gene i is key because it determines the relative expression levels of
the treatments for the gene. That is, ∆ic determines whether treatment 2 is
over-, under-, or nondifferentially expressed with respect to treatment 1.
To model the mean expression magnitude, the possible dependence among
the βic’s of neighboring genes on a chromosome is modeled using either a
two-component finite mixture model [Titterington, Smith and Makov (1985),
Fru¨hwirth-Schnatter (2006)] or a stationary two-state hidden Markov model
[Rabiner (1989), MacDonald and Zucchini (1997)]. The latent average ex-
pression state sic determines whether the expression of gene i, averaged over
treatments and replicates, is “small” (sic = 1) or “large” (sic = 2). In the
absence of differential treatment and replicate effects, the two levels of this
categorical variable correspond, respectively, to low and high reads for the
genes. Conditional on sic, the average expression βic is normally distributed:
βic|sic
indep
∼ N(µsicc, σ
2
sicc
)
with µ1c < µ2c. The latent states s1c, . . . , sIcc follow either a finite mixture
model (FMM) with probability vector Pc = (p1c, p2c) or a hidden Markov
model (HMM) with stationary transition probability matrixAc = ((autc))2×2
with the row sums
∑
t=1,2 autc = 1 for u= 1,2. We denote the two-component
FMM by F2c and the two-state HMM by H2c, assuming independent, non-
informative priors for its dispersion parameters: p(σ2uc)∝ σ
−2
uc for u= 1,2.
To model differential expression, the differential effects ∆1c, . . . ,∆Icc of the
genes are modeled either by a finite mixture model (FMM) F3c with proba-
bility vector Qc = (q1c, q2c, q3c) or by a three-state stationary HMM denoted
by H3c; the matrix of transition probabilities is denoted by Bc = ((bvtc))3×3
with row sums
∑3
t=1 bvtc = 1 for v = 1,2,3. With latent differential states
h1c, . . . , hIcc taking values in {1,2,3}, the values correspond, respectively,
to the gene-specific under-, nondifferential-, and over-expression of treat-
ment 2 relative to treatment 1. Given the state hic, differential effect ∆ic is
distributed as
∆ic|hic ∼


N(φ1c, τ
2
1c), if hic = 1 (under-expressed),
N(0, τ22c), if hic = 2 (nondifferentially-expressed),
N(φ3c, τ
2
3c), if hic = 3 (over-expressed),
(2.2)
where φ1c < 0 and φ3c > 0. Thus, for each chromosome, h1c, . . . , hIcc are the
parameters of interest because they identify the set of DE genes.
We observe that the latent states of both FMM F2c and HMM H2c are
nonexchangeable, being associated with particular biological conditions. The
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priors for the state parameters are designed to reflect this and also to pre-
vent label switching [Scott (2002)]. Specifically, the mean parameters, µ1c
and µ2c are assigned the prior p(µ1c, µ2c) ∝ 1{µ1c≤µ2c−δ} where δ > 0 is a
predetermined constant. The fact that δ is strictly positive guarantees that
µ1c < µ2c and the two states are identifiable.
For the same reason, for the FMM F3c and HMM H3c, we assume that
p(φ1c, φ3c)∝ 1{φ1c<u1,φ3c>l3}, where u1 < 0 and l3 > 0 are prespecified con-
stants that can be chosen as follows. The log-fold change between the over-
and under-expressed categories is at least (l3− u1). From a practical stand-
point, in order to distinguish between these two categories, it is reasonable
to assume that the ratios of their associated ∆ic’s exceed 2. Because of this,
we symmetrically set u1 =−(log 2)/2 and l3 = (log 2)/2. To further facilitate
inferences of the state-specific parameters, informative conjugate priors are
assigned to τ21c, τ
2
2c and τ
2
3c.
2.1. Paired data analysis. Our hmmSeq framework may also accommo-
date paired data, that is, the case when each subject undergoes each of the
treatments. Here we describe the minor changes needed for that purpose.
For a given chromosome c, let Yijkc denote the gene read of the kth subject
of gene i under treatment j, for subject k = 1, . . . ,K. Obviously, because of
the paired data structure there exists dependence between observations on
the same subject. To account for this dependence, we assume that
Yijkc
indep
∼ Poisson(λijkc) where
log(λi1kc) = βic −∆ic + εikc + ρ1k and(2.3)
log(λi2kc) = βic +∆ic + εikc + ρ2k,
with εikc ∼N(0, σ
2
ε) denoting the subject-specific random effects. The other
parameters in the paired-data model have the same interpretations as in
equation (2.1).
2.2. Exploratory data analysis. We have performed an exploratory data
analysis (EDA) to verify some of the hmmSeq model assumptions for the
Marioni et al. (2008) and Zeng et al. (2012) data sets. Both data sets possess
the feature described by Bullard et al. (2010); for libraries under each treat-
ment, 5% of the genes account for over 50% of the total library size, and
10% of the genes account for over 60% of the total library size. Focusing only
on those genes whose reads exceeded nine for all libraries, and ignoring the
replicate effects, we preprocessed the raw counts using the upper-quartile
normalizing technique of Bullard et al. (2010).
For the genes i= 1,2, . . . , Ic of each chromosome, we have computed pre-
liminary estimates of the expression magnitude βic and differential effect
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Fig. 1. Marioni et al. (2008) data set—density plots of preliminary estimates for the
expression magnitudes β and the differential expression effects ∆. (a) Density plot of βˆi
for chromosome 13, (b) density plot of ∆ˆi for chromosome 19.
∆ic by treating these parameters as the fixed effects in a Poisson regres-
sion model. Figure 1 displays graphical summaries of these estimates for a
few chromosomes of the Marioni et al. (2008) data set. The results were sim-
ilar for the other chromosomes. The density plot for the βi’s in Figure 1(a)
and for the ∆i’s in Figure 1(b) are indicative of mixture of densities rep-
resentations for these parameters. Further, data analysis in Section 5.1 will
select the dependence structures of βi’s and ∆i’s by DIC model selection.
For the Zeng et al. (2012) data set, Figure 2 displays density plots for pre-
liminary estimates of the model parameters and also reveals a similar pattern
as the Marioni et al. (2008) data set. The above analysis, together with data
analysis in Section 5.2, suggests the need for mixture models, with first order
dependence to model the expression magnitudes βic and differential effects
Fig. 2. Zeng et al. (2012) data set—density plots of preliminary estimates for the ex-
pression magnitudes β and the differential expression effects ∆. (a) Density plot of βˆi for
chromosome 13, (b) density plot of ∆ˆi for chromosome 9.
HMMSEQ: A HIDDEN MARKOV MODEL 9
∆ic, justifying the use of the hidden Markov models H2c and H3c in the
hmmSeq method.
3. Posterior inference. We investigate the posterior distribution of the
chromosome-specific parameters using Markov chain Monte Carlo (MCMC)
methods. Gibbs sampling cannot be applied to generate the parameters in
equation (2.1) because the Poisson likelihood function is not conjugate to
the normal priors of the parameters. Consequently, we apply the Laplace
approximation [e.g., Zeger and Karim (1991), Chib and Greenberg (1994)] to
generate proposed updates for the equation (2.1) parameters. The proposals
are accepted or rejected by a Metropolis–Hastings probability to compensate
for the use of an approximation instead of the Poisson distribution. This
guarantees the convergence of the Markov chain to the posterior distribution
of the hmmSeq model. We analyze each chromosome separately and, for
simplicity of notation, in this section we omit the chromosome index c.
3.1. Metropolis–Hastings algorithm for HMMs. In this section we present
a Metropolis–Hastings algorithm for the simulation of a general latent pro-
cess {θi, i = 1, . . . , I} that follows an HMM Hm. We use this algorithm in
Section 3.2 to simulate the expression magnitude β and the differential ef-
fects ∆. Under a Laplace approximation, the working values of the read
counts are defined as
wijk = log(λijk) +
Yijk − λijk
λijk
.(3.1)
These working values have an approximate normal distribution, specifically
wijk
approx
∼ N(log(λijk),1/λijk).
For a more general case, suppose θi is the parameter of interest, and its
value at the previous MCMC iteration was θ
(old)
i . Then, the Laplace approx-
imation (3.1) gives us wijk = log (λ
∗
ijk)+(Yijk−λ
∗
ijk)/λ
∗
ijk
approx
∼ N(log(λijk),
1/λ∗ijk), where log (λijk) = ξijk + zijk · θi and log (λ
∗
ijk) = ξijk + zijk · θ
(old)
i .
Let the vectors wi = (wi11,wi12, . . . ,wi2K2)
′, λi = (λi11, λi12, . . . , λi2K2)
′
and λ∗i = (λ
∗
i11, λ
∗
i12, . . . , λ
∗
i2K2
)′. Then wi
approx
∼ N(log (λi),Diag(1/λ
∗
i )).
Defining
w∗i =
∑2
j=1
∑Kj
k=1λ
∗
ijk[zijk(wijk − ξijk)]∑2
j=1
∑Kj
k=1 z
2
ijkλ
∗
ijk
,
we have that w∗i is sufficient for θi and w
∗
i |θi
approx
∼ N(θi,1/
∑2
j=1
∑Kj
k=1 z
2
ijkλ
∗
ijk).
Further assume that the prior of δ is an m-state hidden Markov model (Hm)
with transition matrix Cm, and θi|hi = t ∼ N(νt, κ
2
t ), for t = 1,2, . . . ,m,
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where hi is the hidden state for θi. We marginalize over θi to obtain the
approximate likelihood function
p(w∗i |hi = t)
approx
∼ N
(
νt, κ
2
t +1
/ 2∑
j=1
Kj∑
k=1
z2ijkλ
∗
ijk
)
(3.2)
where t= 1,2, . . . ,m.
The conditional prior probability, P (hi = t|hj , j 6= i), for t = 1,2,3, can be
computed from the transition matrix, Cm, of the HMM Hm.
The normalized product of the conditional prior probability and approx-
imation (3.3) gives the approximate full conditional distribution of the dif-
ferential state hi, from which we propose a new value, h
(prop)
i . We then pro-
pose a new value, θ
(prop)
i , from the approximate full conditional of θi given
hi = h
(prop)
i . The proposed values (h
(prop)
i , θ
(prop)
i ) are jointly accepted or re-
jected by a Metropolis–Hastings probability [Gamerman and Lopes (2006)]
to ensure that the post-burn-in MCMC samples represent draws from model
posterior.
3.2. MCMC procedure. We iteratively generate MCMC samples of the
chromosome-specific parameters by the following procedure:
1. The differential effects ∆1, . . . ,∆I and latent differential states h1, . . . , hI
are generated as in Section 3.1, given the expression magnitudes β, subject-
specific effects ε (set to be 0 for nonpaired data) and treatment-replicate
effects ρ.
2. The mean expression magnitudes β1, . . . , βI and latent states s1, . . . , sI
are generated as in Section 3.1, given the differential effects ∆, subject-
specific effects ε (set to be 0 for nonpaired data) and treatment-replicate
effects ρ.
3. For paired data, the subject-specific effects εik for i = 1, . . . , I and
k = 1, . . . ,K are also generated by a similar Laplace approximation and
Metropolis–Hastings procedure as in step 1.
4. Conditional on the mean expression magnitudes β1, . . . , βI , latent states
s1, . . . , sI , and the fact that µ2−µ1 > δ, the hyperparameters µ1 and µ2 are
jointly sampled from the restricted bivariate normal distribution using the
R package tmvtnorm [Wilhelm and Manjunath (2013)].
5. For latent states h = 1,2,3, s = 1,2, the hyperparameters φh, τ
2
h , σ
2
s
are all generated from their full conditional distributions by Gibbs sampling
steps.
3.3. Detection of DE genes. For each chromosome, interest focuses on
the latent vector of differential states h1, . . . , hI , where, as defined in equa-
tion (2.2), hi = 1 (hi = 3) represents an under-expressed (over-expressed)
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gene in treatment 2. We use the MCMC samples of the differential states to
identify the DE genes while controlling for false discovery rate. Specifically,
we use a Bayesian approach for controlling the FDR level first proposed by
Newton et al. (2004), further studied by Mu¨ller, Parmigiani and Rice (2007),
and subsequently applied in RNA-seq analysis by Lee et al. (2011).
Let q0 be the desired nominal FDR level. In addition, let ri ∈ {0,1} rep-
resent the unknown truth that gene i is differentially expressed (ri = 1) or
nondifferentially expressed (ri = 0). Further, let pi be the posterior prob-
ability that gene i is differentially expressed. Last, let δi ∈ {0,1} denote
the decision of calling gene i differentially expressed (δi = 1) or nondifferen-
tially expressed (δi = 0). Using the MCMC output, we compute the estimate
pˆi =Pr(ri = 1|data) for genes i= 1, . . . ,N on all chromosomes.
A possible decision is to flag all genes with pˆi greater than or equal to a
certain threshold p0. The resulting FDR would then be equal to
FDR =
∑N
i=1(1− ri)1(pˆi≥p0)∑N
i=1 1(pˆi≥p0)
.(3.3)
Hence, the posterior expected FDR would be
F̂DR =
∑N
i=1(1− pˆi)1(pˆi≥p0)∑N
i=1 1(pˆi≥p0)
.(3.4)
Alternatively and more effectively than assigning a prespecified thresh-
old p0, we may control the nominal FDR level q0 [Newton et al. (2004),
Mu¨ller, Parmigiani and Rice (2007)]. Specifically, first we rank genes in de-
creasing order of pˆi. Denote the ordered estimated posterior probabilities by
pˆ(1) > pˆ(2) > · · ·> pˆ(N). Thus, if we declare as differentially expressed the set
of genes such that pˆi ≥ pˆ(d), for each d = 1, . . . ,N , then the corresponding
posterior expected FDR will be
F̂DRd =
∑N
i=1(1− pˆi)1(pˆi≥p(d))∑N
i=1 1(pˆi≥p(d))
=
∑d
i=1(1− pˆ(i))
d
.(3.5)
Finally, the decision rule for detecting DE genes is to flag all genes with
F̂DRd < q0.
4. Simulation study. To compare the accuracy of hmmSeq with exist-
ing RNA-seq techniques, we performed two simulation studies. In the first
study, the data were generated from a Poisson distribution. In the second
simulation study, we generated the data from a negative binomial distri-
bution. Three popular RNA-seq techniques were considered for compar-
isons: edgeR [Robinson, McCarthy and Smyth (2010)], baySeq [Hardcas-
tle (2009)], and TSPM [Auer and Doerge (2011)]. The methods edgeR
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Table 1
Simulation study—parameters for generation of β
Normal components HMM transition matrix FMM probability
β µ1 σ
2
1 µ2 σ
2
2 A P
1 0.37 3.91 2.4
(
0.50 0.50
0.05 0.95
)
(0.1,0.9)
and baySeq have been implemented in R packages publicly available at
http://www.bioconductor.org. R code for TSPM can be downloaded from
http://www.stat.purdue.edu/˜doerge/software/TSPM.R. The R code for
hmmSeq is available in the Supplementary Materials [Cui et al. (2015)].
We first consider a simulation study with data generated from a Poisson
distribution. For each of the following simulations, read counts were simu-
lated for 12 chromosomes having 800 genes each, resulting in a total of 9600
genes. Six replicates of the set of read counts were generated for each of
the two treatments. The replicate effects were assumed to be equal to the
estimates for the biological replicates data of Zeng et al. (2012).
In the simulation study, the gene-specific magnitude factors β and the dif-
ferential expression factors∆ were generated either from the hidden Markov
model or finite mixture model with hyperparameters values given in Ta-
bles 1 and 2. The hyperparameters of the normal components were chosen
to match the estimates for the biological replicates data of Zeng et al. (2012).
The other hyperparameters were chosen according to our experience working
with hidden Markov models [Guha, Li and Neuberg (2008)]. Let “F” denote
a finite mixture model and “H” denote a hidden Markov model. We consider
each model resulting from each possible combination of a FMM or a HMM
for β and a FMM or a HMM for ∆ in a total of 4 possible models. We
denote each model with FF, FH, HF and HH, with the first letter indicating
the process for β and the second letter indicating the process for ∆.
We performmodel selection with the deviance information criterion (DIC)
[Spiegelhalter et al. (2002)]. To evaluate the ability of DIC to discriminate
among the four competing models, we have performed a simulation study.
Table 2
Simulation study—parameters for generation of ∆
Normal components HMM transition matrix FMM probability
∆ φ1 τ
2
1 τ
2
2 φ3 τ
2
3 B Q
−0.4 0.013 0.01 0.4 0.013

0.50 0.25 0.250.10 0.80 0.10
0.25 0.25 0.50

 (0.22,0.56,0.22)
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Table 3
Simulation study—performance of DIC-based model selection
DIC chosen model
FF FH HF HH
True model FF 0.73 0.10 0.07 0.10
FH 0.00 0.77 0.00 0.23
HF 0.07 0.03 0.80 0.10
HH 0.00 0.10 0.00 0.90
Specifically, for each of the 4 possible models, we have simulated 30 data sets.
After that, we have analyzed each simulated data set with the 4 different
hmmSeq models: FF, FH, HF and HH. Then, for each simulated data set we
have conducted DIC model selection. Table 3 presents for each true model
the proportion of times that DIC has chosen each of the 4 competing models.
As we can see from Table 3, the DIC chooses the correct model most of the
time.
To compare hmmSeq with the other competing RNA-seq analysis meth-
ods, we consider their receiver operating characteristic (ROC) curves. The
ROC curve of each method describes the relationship between the true pos-
itive rate (TPR) and the false positive rate (FPR) of gene detection. The
TPR (which is also known as the sensitivity) is defined as the proportion
of truly DE genes that are detected by the method. The FPR is defined
as the proportion of non-DE genes that are erroneously identified as DE.
The greater the area under the ROC curve, the greater the reliability of the
method in detecting DE genes. For each simulation setup of FF, FH, HF
and HH, we plot the ROC curves of (DIC picked) hmmSeq, edgeR, baySeq
and TSPM averaged over 30 repetitions. Figure 3 displays the ROC curves
for the methods hmmSeq (solid line), edgeR (dashed line), baySeq (dotted
line) and TSPM (dot-dashed line) with the areas below the ROC curves
being indicative of the relative accuracies of the methods in detecting DE
genes. While edgeR beat the methods TSPM and baySeq in this simulation,
hmmSeq achieves a substantially higher area under the ROC curve than the
competing methods.
For each of the four competing methods, Figure 4 plots the observed FDR
against the nominal FDR. Ideally, we would like to observe a 45 degree line
through the origin in Figure 4 for each method. Observed FDR of edgeR is
substantially smaller than the nominal FDR. The observed FDR for TSPM
and baySeq, on the other hand, are quite liberal: The FDR for TSPM always
exceeds 40%, while the FDR for baySeq exceeds 35% for most values of
nominal FDR. Finally, FDR for hmmSeq is near and slightly lower than
the 45 degree line. Therefore, hmmSeq is the method that performs best at
controling FDR.
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Fig. 3. For the simulation study of four setups FF (a), FH (b), HF (c) and HH (d),
four panels depict the ROC curves for hmmSeq, edgeR, baySeq and TSPM. Results are
averaged over 30 simulated data sets for each setup, where for each simulated data set we
use the DIC-chosen hmmSeq model.
To investigate the robustness of hmmSeq to overdispersed data, we simu-
lated RNA-seq counts from a negative binomial distribution. This distribu-
tion is assumed by both edgeR and baySeq. Assume that y|λ∼ Poisson(λ)
and λ|r,ψ ∼ gamma(r, (1−ψ)/ψ). Then, unconditionally, we obtain y|r,ψ ∼
negative binomial(r,ψ). The negative binomial mean is m(1) = rψ/(1 − ψ)
and the variance ism(2) = rψ/(1−ψ)2. The variancem(2) =m(1)(1+m(1)/r)
exceeds the mean m(1), reflecting overdispersion; ζ = 1/r is usually called
the dispersion parameter.
HMMSEQ: A HIDDEN MARKOV MODEL 15
Fig. 4. For the simulation study, four panels depict the observed FDR versus nominal
FDR for the methods hmmSeq, TSPM, edgeR and baySeq under four different simulation
setups FF (a), FH (b), HF (c) and HH (d). Results are averaged over 30 simulated data
sets for each setup, where for each simulated data set we use the DIC-chosen hmmSeq
model. The proposed method controls the FDR closest and slightly lower to the 45 degree
line.
The gene-specific magnitude factors β and the differential expression fac-
tors ∆ were generated from a hidden Markov model with parameters values
given in Tables 1 and 2. To generate the negative binomial reads for each
gene i, we first generated the mean m
(1)
ijkc = λijkc by equation (2.1) and the
dispersion parameter ζi from a gamma distribution [as in, e.g., Kvam, Liu
and Si (2012)]. To mimic the dispersion observed in real data sets, the shape
parameter and scale parameter of the gamma distribution were estimated
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Fig. 5. For the negative binomial simulation study, the left panel depicts the ROC curves
for DIC-selected hmmSeq, edgeR, baySeq and TSPM, and the right panel depicts the ob-
served FDR versus nominal FDR for DIC-selected hmmSeq, TSPM, edgeR and baySeq.
(a) ROC curves, (b) FDR control plot.
by the method of moments using the gene-wise dispersion estimates of Zeng
et al. (2012) (biological replicates) available from edgeR. We computed the
gamma distribution parameters r = 1/ζ and ψ = ζµ/(1 + ζµ), and then hi-
erarchically generated negative binomial read counts for 12 chromosomes
having 800 genes each. This simulation procedure was replicated 30 times.
We fit four hmmSeq models to the negative binomial data. In addition,
we fit edgeR, baySeq and TSPM models to the data. DIC chose the true
model (HH in this case) 19 out of 30 times. The ROC curves and FDR
controls are plotted in Figure 5. In the FDR control plot in Figure 5(b),
we find that none of the methods are accurate. The hmmSeq FDR tends
to be large for small nominal FDR, converging to the 45 degree line as the
nominal level increases. In contrast, the observed FDR of baySeq and edgeR
are mostly lower than the nominal FDR. For the ROC plot in Figure 5(a),
hmmSeq achieves the highest area under the ROC curve than the competing
methods, demonstrating its high reliability in detecting DE genes.
5. Data analysis. To illustrate the power and flexibility of our proposed
RNA-seq analysis method, we have applied the hmmSeq method to analyze
three data sets: Marioni et al. (2008) (technical replicates), Zeng et al. (2012)
(biological replicates) and Henn et al. (2013) (paired data). For each of
these three data sets, the treatment-specific replicate effects ρjk are obtained
by the upper-quartile normalizing technique of Bullard et al. (2010). In
addition, we compare the results of the hmmSeq analysis with results of
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TSPM [Auer and Doerge (2011)], baySeq [Hardcastle (2009)] and edgeR
[Robinson, McCarthy and Smyth (2010)] based on their publicly available
R package implementations.
5.1. Marioni et al. (2008) data set. The Marioni et al. (2008) data set
contains RNA-seq data for five technical replicates each of a single sample of
kidney RNA (treatment 1) and liver RNA (treatment 2). Because genes with
mostly small counts are not informative about differential expression, we
have applied the filtering criterion of Auer and Doerge (2011) to eliminate
the genes whose total read counts were less than 10. Additionally, the Y
chromosome was ignored because many of its genes are transcribed on other
chromosomes and the genders of the subjects are unknown. This yielded
17,076 genes for the analysis. Further, we applied the quantile normalization
of Bullard et al. (2010) to preprocess the data. We have fitted four hmmSeq
models (FF, FH, HF and HH) to the data. The DIC favors the FH model
as the best, which implies neighboring genes dependence with respect to the
differential expression parameter ∆. Thus, in the remainder of this section
we present hmmSeq results based on the FH model.
We have applied the hmmSeq, edgeR, baySeq and TSPM methods to the
Marioni et al. (2008) data set with a nominal FDR of q0 = 0.001 [threshold
adopted by Auer and Doerge (2011)]. Recall that the simulation study in
Section 4 had indicated that the actual FDR of TSPM and baySeq is rel-
atively insensitive to the value of q0 and is substantially higher when q0 is
small. The sets of DE genes identified by the methods hmmSeq, edgeR, bay-
Seq and TSPM are summarized in Figure 6(a). The method TSPM detected
9076 DE genes. In contrast, the hmmSeq method discovered only 2831 DE
genes.
A closer examination sheds light on the differing sets of genes detected
by TSPM and hmmSeq. Of the genes discovered by hmmSeq, as many as
2818 genes (99.5%) were also identified by the TSPM method. Focusing on
the 6258 genes identified as DE by TSPM but not by hmmSeq, we find that
TSPM flagged most of them as DE genes because they have extreme values
of mean log2-fold change (from output of TSPM) for the treatments. In
particular, we have observed that for the 111 genes with log2-fold change less
than −20, all five gene-specific reads for liver RNA were zero. Table 4 lists
10 randomly selected genes from this set, which reveals that the read counts
for kidney, although positive, are not in hundreds or thousands like typical
DE genes. Thus, TSPM tends to classify genes with 0 observations under
any single condition as DE, while hmmSeq takes the variational magnitude
into consideration. The result for edgeR lies between hmmSeq and TSPM.
Similarly, all 33 genes with mean log2-fold change greater than 20 have
zero counts for kidney and relatively small counts for liver. The hmmSeq
method called all of them non-DE, but TSPM classified them as DE genes
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Fig. 6. Venn diagrams for the DE genes identified by the methods hmmSeq, baySeq,
edgeR and TSPM in the data analyses. (a) Technical replicates of Marioni et al. (2008),
(b) biological replicates of Zeng et al. (2012), (c) paired biological replicates of Henn et al.
(2013).
due to their high mean log2-fold changes. The former call seems more rea-
sonable, given that the read counts of truly DE genes are typically several
orders of magnitude higher.
5.2. Zeng et al. (2012) data set. We have applied hmmSeq to the data
set of Zeng et al. (2012), which contains samples from 2 regions of the
human brain, frontal pole and hippocampus, with 6 biological replicates
for each region. Data sets with biological replicates typically exhibit sub-
stantial over-dispersion or higher variability relative to the Poisson distri-
bution. Researchers often model extra-Poisson variability using the bino-
mial, negative binomial or Bayesian hierarchical Poisson models. We ac-
count for over-dispersion through hierarchical priors on the parameters in
equation (2.1), for example, through random differential expression factors.
There were 13,574 genes available for analysis after filtering (read sums for
all the libraries did not exceed 9). Further, we have applied the quantile
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Table 4
Marioni et al. (2008) data set—ten randomly selected genes with mean log2-fold change greater than 20 that were identified as DE genes
by the TSPM method. RjLkK denotes jth run, kth replicate for kidney; RjLkL denotes jth run, kth replicate for liver
Gene ID R1L1K R1L3K R1L7K R2L2K R2L6K R1L2L R1L4L R1L6L R1L8L R2L3L
ENSG00000198693 2 1 2 2 8 0 0 0 0 0
ENSG00000162746 3 4 2 4 4 0 0 0 0 0
ENSG00000168243 4 4 1 3 3 0 0 0 0 0
ENSG00000188935 2 0 3 5 5 0 0 0 0 0
ENSG00000173284 5 2 5 2 3 0 0 0 0 0
ENSG00000114113 4 5 4 1 1 0 0 0 0 0
ENSG00000169836 5 2 3 2 3 0 0 0 0 0
ENSG00000170180 2 2 3 2 5 0 0 0 0 0
ENSG00000186952 3 4 2 4 2 0 0 0 0 0
ENSG00000164385 3 2 3 3 4 0 0 0 0 0
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normalization of Bullard et al. (2010) to preprocess the data. We have fit-
ted four hmmSeq models (FF, FH, HF and HH) to the Zeng et al. (2012)
data set. DIC chooses HH as the best model, which indicates neighboring
genes dependence with respect both to the differential expression parameter
∆ and to the expression level parameter β. Thus, in the remainder of this
section we present hmmSeq results based on the HH model.
We have applied the hmmSeq, edgeR, baySeq and TSPM methods to
the data set of Zeng et al. (2012) with a nominal FDR q0 = 0.05. TSPM,
edgeR and baySeq, respectively, identified 236, 134 and 278 DE genes. The
hmmSeq technique identified 333 DE genes. The overlapping set of DE genes
for the methods are summarized in Figure 6(b) and reveal a greater lack of
agreement between the methods than for the Marioni et al. (2008) data
set. Only 1 gene is identified as DE by all four methods. This low level
of agreement is a result of the low overlap that TSPM has with the other
methods. In contrast, hmmSeq has relatively large overlap both with edgeR
(76 genes) and baySeq (110 genes).
We have investigated the biological implications of the results obtained
with the hmmSeq analysis of differential expression of the hippocampus to
the frontal pole. Though we expect a modest amount of differentially ex-
pressed genes, we do find some meaningful results that are supported in the
literature. There is an increase in gene expression of Akt2 in the hippocam-
pus compared to the frontal pole. Akt2 is a gene involved in insulin signal-
ing, which occurs in the hippocampus [Robertson et al. (2010), Agrawal and
Gomez-Pinilla (2012)]. In addition, Wnt7B is upregulated in the hippocam-
pus where Wnt activity has been implicated in signaling of hippocampal
synapses [Gogolla et al. (2009)]. Last, STAT5A is known to be expressed in
the hippocampus [Kalita et al. (2013)], and our results show this upregu-
lation. Taken all together, the results our hmmSeq method produced show
biologically relevant genes when comparing the hippocampus to the frontal
pole. In addition, we have conducted a functional analysis using DAVID
[Huang, Sherman and Lempicki (2009a, 2009b)]; both our hmmSeq method
and edgeR identified differentially expressed genes that are known to be ex-
pressed in brain tissue. The biological experiment presented tries to identify
genes that are differentially expressed between two types of brain tissue.
These results, taken in perspective with the biological experiment, suggest
that the genes identified as differentially expressed via these two methods
are relevant to the biological problem and help support the validity and
accuracy of our predictions.
5.3. Henn et al. (2013) paired data set. Here we illustrate the application
of the hmmSeq method to paired data sets with an analysis of a subset of
an RNA-seq data set obtained by Henn et al. (2013) on immune response
to a trivalent influenza vaccine. The original data set contains RNA-seq
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data from B cell samples for five subjects before vaccination (day 0) and
for each of 10 days after vaccination (days 1 through 10). We consider a
paired subset of three previously vaccinated subjects in the original data
set, where we compare gene expression before vaccination to gene expression
after vaccination. Since peak B cell response usually appears 5–9 days post-
vaccination, we apply our hmmSeq method to identify B cell gene differential
expression between day 0 and day 7.
For the hmmSeq analysis, we first estimate the variance σ2ε of subject-
specific random effects from the data. Specifically, for each gene we have
fitted a generalized linear mixed model with random subject effects, resulting
in an estimated random effects variance for each gene. We then use the
median of these estimates of random effects variances as an empirical Bayes
estimate of σ2ε . In addition, we have fitted the four hmmSeq models FF,
FH, HF and HH. We have found that the DIC favors the FF model, that
is, a finite mixture model without neighboring genes dependence. Thus, in
the remainder of this section we present hmmSeq results based on the FF
model.
We have analyzed this immune response data set using a nominal FDR
of 0.05. To accommodate the paired data structure, in the edgeR analysis
we include subject-specific fixed effects. Such edgeR analysis identifies 175
genes as differentially expressed. The TSPM that we used ignores the paired
structure and treats all observations for each gene as independent, which
identifies a total of 186 genes. Finally, in a paired baySeq analysis 100 genes
are flagged to be DE. Figure 6(c) presents a Venn diagram that summarizes
the results for TSPM, edgeR, baySeq and hmmSeq.
In order to further evaluate the competing methods, we compare their
results to those found by Henn et al. (2013). Henn et al. (2013) used the
RNA-seq data set from all 11 days, whereas we used only the data from
days 0 and 7. Thus, here we use the results of Henn et al. (2013) as a
benchmark. Specifically, Henn et al. (2013) identified a set of 742 genes as
what they call the plasma cell gene signature (PCgs), that is, genes that have
a common significant time-varying signature. Hence, in Table 5 we list the
overlap of the PCgs set with the genes identified as differentially expressed
by hmmSeq, edgeR, baySeq and TSPM. Our proposed hmmSeq method
obtains the largest overlap with PCgs set (130 genes), and edgeR overlaps
Table 5
Henn et al. (2013) data set—overlap of plasma cell gene signature (PCgs) set with genes
identified by hmmSeq, edgeR, baySeq and TSPM
hmmSeq edgeR baySeq TSPM
PCgs 130 121 7 1
22 CUI, GUHA, FERREIRA AND TEGGE
121 genes with PCgs. We recall from Section 4 that hmmSeq and edgeR
are the two methods with the highest area under the ROC curve. Thus, the
overlap with the PCgs set shows the power of DE genes identification of the
proposed hmmSeq method.
6. Conclusion. We propose hmmSeq, a method based on Bayesian hier-
archical models for detecting DE genes between two treatments for paired or
nonpaired data in RNA-seq analyses. The approach employs hidden Markov
models to account for the statistical dependence between the gene counts
of neighboring genes observed in many RNA-seq data sets. The hmmSeq
model can be applied to studies with either biological or technical repli-
cates, automatically adjusting for any overdispersion relative to the Poisson
distribution. Through simulated and real data sets, we compare and con-
trast the performance of hmmSeq with some well-known methods in the
literature, demonstrating the reliability and success of our approach in the
identification of DE genes.
We have developed DIC-based model selection to decide for each data set
whether HMM or FMM should be used to model gene expression magnitude
and/or differential expression. For the Marioni et al. (2008) data set the
DIC-selected model is the FH model, for the Zeng et al. (2012) data set
the DIC-selected model is the HH model, and for the Henn et al. (2013)
data set the DIC-selected model is the FF model. Thus, for one data set
there appears to be neighboring genes dependence in expression magnitude.
Even more important, for two data sets there is evidence of neighboring
genes dependence in differential expression. This co-differential expression
can be justified by how ancient species organized their genomes and by
evolution. Specifically, more ancient species, such as bacteria, organize their
genomes based on operons, where genes involved in the same process or
needed at the same time are transcribed in tandem [Alberts et al. (1994)].
Throughout evolution, operons have been divided into individual genes, but
genes involved in the same process now reside in gene clusters [Hurst, Pa´l
and Lercher (2004)]. Thus, neighboring genes tend to be jointly differentially
expressed.
To further examine spatial genomic dependence (and clustering) among
detected DE genes, we have devised the following statistical test. Consider
any detected DE gene and the next detected DE gene in the chromosome as
neighboring DE genes. Consider the distance between two neighboring DE
genes as the number of non-DE genes between them. If there is no spatial
dependence, then all the distances between any two neighboring DE genes
should be a random sample from a geometric distribution. Hence, to test
for spatial dependence, we collect all the distances between neighboring DE
genes and conduct a goodness-of-fit test of the hypothesis that the empirical
distribution equals the null theoretical geometric distribution. We use this
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procedure to test for spatial genomic dependence for DE calls from edgeR
and hmmSeq. First, we performed this test for the Henn et al. (2013) data set
for which hmmSeq prefers finite mixture model and spatial independence.
The spatial genomic dependence test for DE calls from edgeR and hmmSeq
yields p-values equal to 0.2201 and 0.5178, respectively, further supporting
hmmSeq suggestion of spatial independence. Second, we performed this test
for the two real data sets for which hmmSeq prefers spatial dependence,
that is, the Marioni et al. (2008) and the Zeng et al. (2012) data sets. For
the Marioni et al. (2008) data set, the spatial dependence test for DE calls
from both hmmSeq and edgeR yield p-values smaller than 2.2e–16. That is,
even though edgeR does not account for spatial dependence, its detected
DE genes for the Marioni et al. (2008) data set cluster spatially. For the
Zeng et al. (2012) data set, edgeR only detected 134 DE genes which did
not provide enough power for the goodness-of-fit data set (p-value greater
than 0.9). In contrast, there is strong statistical evidence that the 333 genes
identified by hmmSeq as DE cluster spatially (p-value smaller than 2.2e–
16). Therefore, these data sets point to the need to consider spatial genomic
dependence in studies of differential gene expression.
In addition to genomic spatial dependence among genes based on genomic
position, for future research work we plan to extend hmmSeq to include
other sources of dependence among genes. Recent experimental techniques
such as HiC and ChIA-PET allow for the identification of explicit promoter–
promoter and promoter–enhancer–promoter interactions [Edelman and Fraser
(2012), Mercer and Mattick (2013), van Arensbergen, van Steensel and
Bussemaker (2014)]. In addition, we note that genes that belong to the
same active functional pathways tend to be co-expressed [Tegge, Caldwell
and Xu (2012)]. This extension of hmmSeq may need a non-Markovian spa-
tial correlation model. We leave this challenging inferential problem to future
research.
DE gene call lists are frequently used in downstream pathway function
calls in what is known as functional enrichment analysis. Because functional
enrichment analysis methods usually assume independence of DE gene calls,
caution needs to be taken when using the DE gene call lists generated by
hmmSeq. When hmmSeq decides that the best model is a finite mixture
model without spatial dependence, then one can use hmmSeq’s DE gene
call list without any concern. However, when hmmSeq decides that a spa-
tial dependence model is warranted, then the assumption of independence
no longer holds. This opens up a tremendous opportunity for future re-
search that performs joint differential expression gene calls and functional
enrichment analysis. We envision this joint analysis may be implemented
by extending hmmSeq to incorporate information on functional pathway
networks.
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In terms of computational time, on a desktop with a 2.3 GHz proces-
sor and 4 GB memory, hmmSeq takes approximately 3 hours to analyze
a 1200-gene chromosome. Although it does take a longer time than other
methods, hmmSeq often achieves a higher accuracy of DE gene detection
than other methods by a realistic model that allows for spatial genomic de-
pendence. Moreover, the computational time of all the considered statistical
methods is negligible when compared to the time (on the order of months
or years) required by subject-matter scientists to perform experiments to
obtain RNA-seq data. Furthermore, to limit the computational time the
hmmSeq analysis can be performed in parallel for individual chromosomes.
Finally, when compared to the high costs of RNA-seq extraction, the infor-
mation gains obtained by the hmmSeq methodology seem well worth the
relatively low computational costs.
The hmmSeq method we propose relies on a single user-specified “tun-
ing” parameter q0, that is, the nominal false discovery rate. A default value
for q0 between 0.001 or 0.05 has produced satisfactory results for all the
data sets, real or simulated, that we have analyzed, facilitating “black box”
applications of hmmSeq. Future work will focus on extending hmmSeq to
investigations with more than two treatments. An R package implementing
the hmmSeq framework will be submitted to CRAN upon publication of the
manuscript.
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SUPPLEMENTARY MATERIAL
Supplement to “hmmSeq: A hidden Markov model for detecting differ-
entially expressed genes from RNA-seq data.”
(DOI: 10.1214/15-AOAS815SUPP; .zip). The R code for hmmSeq.
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